# Reduced Contrast Administration in Contrast-enhanced Spectral Mammography (CESM)

> **NCT03008031** · NA · TERMINATED · sponsor: **Maastricht University Medical Center** · enrollment: 11 (actual)

## Conditions studied

- Breast Neoplasm
- Contrast-enhanced Spectral Mammography

## Interventions

- **PROCEDURE:** CESM with a reduced dose of contrast agent

## Key facts

- **NCT ID:** NCT03008031
- **Lead sponsor:** Maastricht University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-01
- **Primary completion:** 2020-04
- **Final completion:** 2020-04
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2022-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03008031

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03008031, "Reduced Contrast Administration in Contrast-enhanced Spectral Mammography (CESM)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03008031. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*